(MZX) Masterflex SE - Ratings and Ratios
Tubing, Pumps, Fluid Handling, Connectors, Precision
MZX EPS (Earnings per Share)
MZX Revenue
Description: MZX Masterflex SE
Masterflex SE, listed on XETRA under the ticker symbol MZX, is a German company operating in the Specialty Chemicals sub-industry. The companys stock is characterized by its relatively stable performance, reflected in its moving averages, indicating a positive trend.
To assess the investment potential of Masterflex SE, key financial metrics are crucial. The companys market capitalization stands at 129.85M EUR, suggesting a relatively small-cap stock with potential for growth. The Price-to-Earnings (P/E) ratio is 15.34, which is moderate and indicates that the stock might be reasonably valued. However, the forward P/E is not available, making it challenging to assess future earnings expectations.
The Return on Equity (RoE) of 13.34% is a significant indicator of Masterflex SEs profitability, suggesting that the company is generating substantial returns for its shareholders. This metric is particularly important as it reflects the companys ability to utilize its equity financing effectively.
Key economic drivers for Masterflex SE include the overall demand for specialty chemicals, which are used in a wide range of applications across various industries, including manufacturing, pharmaceuticals, and automotive. The companys performance is likely influenced by factors such as global economic growth, industrial production levels, and trends in the chemical industry, including the shift towards more sustainable and environmentally friendly products.
To further evaluate Masterflex SEs investment potential, it is essential to monitor its revenue growth, profit margins, and cash flow generation. Additionally, analyzing the companys debt-to-equity ratio, interest coverage, and other solvency metrics can provide insights into its financial health and ability to navigate economic downturns.
MZX Stock Overview
| Market Cap in USD | 165m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
MZX Stock Ratings
| Growth Rating | 83.4% |
| Fundamental | 70.9% |
| Dividend Rating | 60.8% |
| Return 12m vs S&P 500 | 12.7% |
| Analyst Rating | - |
MZX Dividends
| Dividend Yield 12m | 2.28% |
| Yield on Cost 5y | 6.00% |
| Annual Growth 5y | 48.17% |
| Payout Consistency | 63.0% |
| Payout Ratio | 31.4% |
MZX Growth Ratios
| Growth Correlation 3m | 72.2% |
| Growth Correlation 12m | 71.1% |
| Growth Correlation 5y | 87.6% |
| CAGR 5y | 26.58% |
| CAGR/Max DD 5y | 0.69 |
| Sharpe Ratio 12m | -0.08 |
| Alpha | 32.72 |
| Beta | 0.159 |
| Volatility | 37.72% |
| Current Volume | 1.8k |
| Average Volume 20d | 1.9k |
| Stop Loss | 13.2 (-4%) |
| Signal | 0.82 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (8.43m TTM) > 0 and > 6% of Revenue (6% = 5.96m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 0.87pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 38.23% (prev 17.45%; Δ 20.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 13.0m > Net Income 8.43m (YES >=105%, WARN >=100%) |
| Net Debt (-10.3m) to EBITDA (18.2m) ratio: -0.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.55 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (9.50m) change vs 12m ago 0.39% (target <= -2.0% for YES) |
| Gross Margin 61.23% (prev 58.84%; Δ 2.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 102.9% (prev 104.3%; Δ -1.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.90 (EBITDA TTM 18.2m / Interest Expense TTM 1.28m) >= 6 (WARN >= 3) |
Altman Z'' 5.50
| (A) 0.39 = (Total Current Assets 48.7m - Total Current Liabilities 10.7m) / Total Assets 97.7m |
| (B) 0.27 = Retained Earnings (Balance) 26.1m / Total Assets 97.7m |
| (C) 0.13 = EBIT TTM 12.6m / Avg Total Assets 96.6m |
| (D) 1.14 = Book Value of Equity 35.7m / Total Liabilities 31.4m |
| Total Rating: 5.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.90
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 7.07% = 3.53 |
| 3. FCF Margin 10.77% = 2.69 |
| 4. Debt/Equity 0.30 = 2.45 |
| 5. Debt/Ebitda 1.10 = 1.63 |
| 6. ROIC - WACC 8.08% = 10.10 |
| 7. RoE 13.34% = 1.11 |
| 8. Rev. Trend -20.87% = -1.04 |
| 9. Rev. CAGR 3.28% = 0.41 |
| 10. EPS Trend 20.76% = 0.52 |
| 11. EPS CAGR -12.00% = -1.50 |
What is the price of MZX shares?
Over the past week, the price has changed by -5.82%, over one month by +8.27%, over three months by +24.75% and over the past year by +31.77%.
Is Masterflex SE a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MZX is around 15.79 EUR . This means that MZX is currently undervalued and has a potential upside of +14.84% (Margin of Safety).
Is MZX a buy, sell or hold?
What are the forecasts/targets for the MZX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.1 | 24.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17.2 | 25.1% |
MZX Fundamental Data Overview
Market Cap EUR = 141.9m (141.9m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 10.3m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.7614
P/S = 1.4197
P/B = 2.1362
Beta = 0.735
Revenue TTM = 99.4m EUR
EBIT TTM = 12.6m EUR
EBITDA TTM = 18.2m EUR
Long Term Debt = 18.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 1.56m EUR (from shortTermDebt, last quarter)
Debt = 20.0m EUR (Calculated: Short Term 1.56m + Long Term 18.4m)
Net Debt = -10.3m EUR (from netDebt column, last quarter)
Enterprise Value = 151.5m EUR (141.9m + Debt 20.0m - CCE 10.3m)
Interest Coverage Ratio = 9.90 (Ebit TTM 12.6m / Interest Expense TTM 1.28m)
FCF Yield = 7.07% (FCF TTM 10.7m / Enterprise Value 151.5m)
FCF Margin = 10.77% (FCF TTM 10.7m / Revenue TTM 99.4m)
Net Margin = 8.48% (Net Income TTM 8.43m / Revenue TTM 99.4m)
Gross Margin = 61.23% ((Revenue TTM 99.4m - Cost of Revenue TTM 38.5m) / Revenue TTM)
Tobins Q-Ratio = 4.24 (Enterprise Value 151.5m / Book Value Of Equity 35.7m)
Interest Expense / Debt = 1.32% (Interest Expense 264.0k / Debt 20.0m)
Taxrate = 26.12% (from yearly Income Tax Expense: 2.93m / 11.2m)
NOPAT = 9.34m (EBIT 12.6m * (1 - 26.12%))
Current Ratio = 4.55 (Total Current Assets 48.7m / Total Current Liabilities 10.7m)
Debt / Equity = 0.30 (Debt 20.0m / last Quarter total Stockholder Equity 66.0m)
Debt / EBITDA = 1.10 (Net Debt -10.3m / EBITDA 18.2m)
Debt / FCF = 1.87 (Debt 20.0m / FCF TTM 10.7m)
Total Stockholder Equity = 63.2m (last 4 quarters mean)
RoA = 8.63% (Net Income 8.43m, Total Assets 97.7m )
RoE = 13.34% (Net Income TTM 8.43m / Total Stockholder Equity 63.2m)
RoCE = 15.50% (Ebit 12.6m / (Equity 63.2m + L.T.Debt 18.4m))
RoIC = 13.98% (NOPAT 9.34m / Invested Capital 66.8m)
WACC = 5.91% (E(141.9m)/V(161.8m) * Re(6.60%)) + (D(20.0m)/V(161.8m) * Rd(1.32%) * (1-Tc(0.26)))
Shares Correlation 5-Years: -70.70 | Cagr: -0.31%
Discount Rate = 6.60% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈10.3m ; Y1≈12.7m ; Y5≈21.6m
Fair Price DCF = 38.25 (DCF Value 367.9m / Shares Outstanding 9.62m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: -20.87 | Revenue CAGR: 3.28%
Rev Growth-of-Growth: 2.41
EPS Correlation: 20.76 | EPS CAGR: -12.00%
EPS Growth-of-Growth: -13.89